Anteris Technologies Ltd. (AU:AVR) has released an update.
Anteris Technologies Ltd, an Australian structural heart company with a global presence, announces its Annual General Meeting scheduled for May 29, 2024, to be held in Sydney and via webcast. The company highlights their leading product, the DurAVRTM THV, a unique heart valve designed to address aortic stenosis using patented tissue technology and an innovative delivery system. Anteris Technologies aims to offer superior solutions for structural heart disease patients and transform the market with its advanced medical devices.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.
